Somatostatin in the dentate gyrus

Progress in Brain Research

Volumn 163, Issue , 2007, Pages 265-284

  Tallent, Melanie K ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

cognition; cortistatin; electrophysiology; epilepsy; interneuron; long term potentiation; neuropeptide; somatostatin

Indexed keywords

CORTISTATIN; MOLECULAR LAYER; NEUROPEPTIDE; SOMATOSTATIN; SOMATOSTATIN RECEPTOR; UNCLASSIFIED DRUG; VOLTAGE GATED CALCIUM CHANNEL;

ALZHEIMER DISEASE; ASSOCIATION; BRAIN; BRAIN FUNCTION; BRAIN ISCHEMIA; COGNITION; CYCLIC AMP RESPONSIVE ELEMENT; DENDRITE; DENTATE GYRUS; DRUG INHIBITION; ELECTROPHYSIOLOGY; ENVIRONMENT; EPILEPSY; EXCITOTOXICITY; GENE; GRANULE CELL; HIPPOCAMPUS; HUMAN; INTERNEURON; LEARNING; LONG TERM POTENTIATION; MODULATION; NERVE CELL; NERVE CELL PLASTICITY; NEUROMODULATION; NONHUMAN; POPULATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SEIZURE; SIGNAL NOISE RATIO; SPATIAL MEMORY; STIMULATION; SYNAPSE; TRAUMATIC BRAIN INJURY; VALIDATION PROCESS;

ANIMALS; DENTATE GYRUS; HUMANS; INTERNEURONS; SOMATOSTATIN;

EID: 34548216796     PISSN: 00796123     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0079-6123(07)63016-7     Document Type: Review

References (160)

1. Agren H., and Lundqvist G. Low levels of somatostatin in human CSF mark depressive episodes. Psychoneuroendocrinology 9 3 (1984) 233-248
2. Amaral D.G., Insausti R., and Campbell M.J. Distribution of somatostatin immunoreactivity in the human dentate gyrus. J. Neurosci. 8 9 (1988) 3306-3316
3. Andrade J.P., Fernando P.M., Madeira M.D., Paula-Barbosa M.M., Cadete-Leite A., and Zimmer J. Effects of chronic alcohol consumption and withdrawal on the somatostatin-immunoreactive neurons of the rat hippocampal dentate hilus. Hippocampus 2 1 (1992) 65-71
4. Arancibia S., Payet O., Givalois L., and Tapia-Arancibia L. Acute stress and dexamethasone rapidly increase hippocampal somatostatin synthesis and release from the dentate gyrus hilus. Hippocampus 11 4 (2001) 469-477
5. Aronin N., Cooper P.E., Lorenz L.J., Bird E.D., Sagar S.M., Leeman S.E., and Martin J.B. Somatostatin is increased in the basal ganglia in Huntington disease. Ann. Neurol. 13 5 (1983) 519-526
6. Austin J.E., and Buckmaster P.S. Recurrent excitation of granule cells with basal dendrites and low interneuron density and inhibitory postsynaptic current frequency in the dentate gyrus of macaque monkeys. J. Comp. Neurol. 476 3 (2004) 205-218
7. 2+ signaling in mouse dentate gyrus. J. Neurophysiol. 88 6 (2002) 3078-3086
8. Bendotti C., Vezzani A., Tarizzo G., and Samanin R. Increased expression of GAP-43, somatostatin and neuropeptide Y mRNA in the hippocampus during development of hippocampal kindling in rats. Eur. J. Neurosci. 5 10 (1993) 1312-1320
9. Bereiter D.A. Morphine and somatostatin analogue reduce c-fos expression in trigeminal subnucleus caudalis produced by corneal stimulation in the rat. Neuroscience 77 3 (1997) 863-874
10. Bering R., Draguhn A., Diemer N.H., and Johansen F.F. Ischemia changes the coexpression of somatostatin and neuropeptide Y in hippocampal interneurons. Exp. Brain. Res. 115 3 (1997) 423-429
11. Blackmer T., Larsen E.C., Bartleson C., Kowalchyk J.A., Yoon E.-J., Preininger A.M., Alford S., Hamm H.E., and Martin T.F.J. G protein [beta][gamma] directly regulates SNARE protein fusion machinery for secretory granule exocytosis. Nat. Neurosci. 8 4 (2005) 421-425
12. Blake A.D. Somatostatin receptor subtype 1 (sst(1)) regulates intracellular 3′,5′-cyclic adenosine monophosphate accumulation in rat embryonic cortical neurons: evidence with L-797,591, an sst(1)-subtype-selective nonpeptidyl agonist. Neuropharmacology 40 4 (2001) 590-596
13. Boehm S., and Betz H. Somatostatin inhibits excitatory transmission at rat hippocampal synapses via presynaptic receptors. J. Neurosci. 17 11 (1997) 4066-4075
14. Bouilleret V., Schwaller B., Schurmans S., Celio M.R., and Fritschy J.M. Neurodegenerative and morphogenic changes in a mouse model of temporal lobe epilepsy do not depend on the expression of the calcium-binding proteins parvalbumin, calbindin, or calretinin. Neuroscience 97 1 (2000) 47-58
15. Brazeau P., Vale W., Burgus R., Ling N., Rivier J., and Guillemin R. Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science 129 (1972) 77-79
16. Bruno J., Yu Y., Song J., and Berlowitz M. Molecular cloning and functional expression of a novel brain somatostatin receptor. PNAS 89 (1992) 11151-11155
17. Buckmaster P.S., and Dudek F.E. Neuron loss, granule cell axon reorganization, and functional changes in the dentate gyrus of epileptic kainate-treated rats. J. Comp. Neurol. 385 3 (1997) 385-404
18. Buckmaster P.S., Kunkel D.D., Robbins R.J., and Schwartzkroin P.A. Somatostatin-immunoreactivity in the hippocampus of mouse, rat, guinea pig, and rabbit. Hippocampus 4 2 (1994) 167-180
19. Calbet M., Guadano-Ferraz A., Spier A.D., Maj M., Sutcliffe J.G., Przewlocki R., and de Lecea L. Cortistatin and somatostatin mRNAs are differentially regulated in response to kainate. Brain Res. Mol. Brain Res. 72 1 (1999) 55-64
20. Chan-Palay V. Somatostatin immunoreactive neurons in the human hippocampus and cortex shown by immunogold/silver intensification on vibratome sections: coexistence with neuropeptide Y neurons, and effects in Alzheimer-type dementia. J. Comp. Neurol. 260 2 (1987) 201-223
21. Chesselet M.F., and Reisine T.D. Somatostatin regulates dopamine release in rat striatal slices and cat caudate nuclei. J. Neurosci. 3 1 (1983) 232-236
22. Chronwall B.M., Chase T.N., and O'donohue T.L. Coexistence of neuropeptide Y and somatostatin in rat and human cortical and rat hypothalamic neurons. Neurosci. Lett. 52 3 (1984) 213-217
23. Connor M., Ingram S.L., and Christie M.J. Cortistatin increase of a potassium conductance in rat locus coeruleus in vitro. Br. J. Pharmacol. 122 8 (1997) 1567-1572
24. Cook J.L., Marcheselli V., Alam J., Deininger P.L., and Bazan N.G. Temporal changes in gene expression following cryogenic rat brain injury. Brain Res. Mol. Brain Res. 55 1 (1998) 9-19
25. Cooper E.C., Aldape K.D., Abosch A., Barbaro N.M., Berger M.S., Peacock W.S., Jan Y.N., and Jan L.Y. Colocalization and coassembly of two human brain M-type potassium channel subunits that are mutated in epilepsy. Proc. Natl. Acad. Sci. U.S.A. 97 9 (2000) 4914-4919
26. Cowles R.A., Segura B.J., and Mulholland M.W. Regulation of carbachol-induced c-fos mRNA expression in AR42J cells by somatostatin receptor subtypes 1, 2, and 3. Pancreas 25 3 (2002) 239-244
27. Csaba Z., Pirker S., Lelouvier B., Simon A., Videau C., Epelbaum J., Czech T., Baumgartner C., Sperk G., and Dournaud P. Somatostatin receptor type 2 undergoes plastic changes in the human epileptic dentate gyrus. J. Neuropathol. Exp. Neurol. 64 11 (2005) 956-969
28. Csaba Z., Richichi C., Bernard V., Epelbaum J., Vezzani A., and Dournaud P. Plasticity of somatostatin and somatostatin sst2A receptors in the rat dentate gyrus during kindling epileptogenesis. Eur. J. Neurosci. 19 9 (2004) 2531-2538
29. Davies P., Katzman R., and Terry R.D. Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementia. Nature 288 5788 (1980) 279-280
30. De Lanerolle N.C., Kim J.H., Robbins R.J., and Spencer D.D. Hippocampal interneuron loss and plasticity in human temporal lobe epilepsy. Brain Res. 495 2 (1989) 387-395
31. De Lanerolle N.C., Kim J.H., Williamson A., Spencer S.S., Zaveri H.P., Eid T., and Spencer D.D. A retrospective analysis of hippocampal pathology in human temporal lobe epilepsy: evidence for distinctive patient subcategories. Epilepsia 44 5 (2003) 677-687
32. de Lecea L., Criado J.R., Prospero-Garcia O., Gautivik K.M., Schweitzer P., Danielson P.E., Dunlop C.L.M., Siggins G.R., Henriksen S.J., and Sutcliffe J.G. A cortical neuropeptide with neuronal depressant and sleep-modulating properties. Nature 381 (1996) 242-245
33. de Lecea L., Del Rio J.A., Criado J.R., Alcantara S., Morales M., Danielson P.E., Henriksen S.J., Soriano E., and Sutcliffe J.G. Cortistatin is expressed in a distinct subset of cortical interneurons. J. Neurosci. 17 15 (1997) 5868-5880
34. de Lecea L., Ruiz-Lozano P., Danielson P.E., Peelle-Kirley J., Foye P.E., Frankel W.N., and Sutcliffe J.G. Cloning, mRNA expression, and chromosomal mapping of mouse and human preprocortistatin. Genomics 42 3 (1997) 499-506
35. Dickson S.L., Viltart O., Bailey A.R., and Leng G. Attenuation of the growth hormone secretagogue induction of Fos protein in the rat arcuate nucleus by central somatostatin action. Neuroendocrinology 66 3 (1997) 188-194
36. Dournaud P., Cervera-Pierot P., Hirsch E., Javoy-Agid F., Kordon C., Agid Y., and Epelbaum J. Somatostatin messenger RNA-containing neurons in Alzheimer's disease: an in situ hybridization study in hippocampus, parahippocampal cortex and frontal cortex. Neuroscience 61 4 (1994) 755-764
37. 2A in rat brain using a specific anti-peptide antibody. J. Neurosci. 16 14 (1996) 4468-4478
38. Dournaud P., Jazat-Poindessous F., Slama A., Lamour Y., and Epelbaum J. Correlations between water maze performance and cortical somatostatin mRNA and high-affinity binding sites during ageing in rats. Eur. J. Neurosci. 8 3 (1996) 476-485
39. Edvinsson L., Minthon L., Ekman R., and Gustafson L. Neuropeptides in cerebrospinal fluid of patients with Alzheimer's disease and dementia with frontotemporal lobe degeneration. Dementia 4 3-4 (1993) 167-171
40. Epelbaum J., Ruberg M., Moyse E., Javoy-Agid F., Dubois B., and Agid Y. Somatostatin and dementia in Parkinson's disease. Brain Res. 278 1-2 (1983) 376-379
41. Figueredo-Cardenas G., Morello M., Sancesario G., Bernardi G., and Reiner A. Colocalization of somatostatin, neuropeptide Y, neuronal nitric oxide synthase and NADPH-diaphorase in striatal interneurons in rats. Brain Res. 735 2 (1996) 317-324
42. Florio T., Yao H., Carey K.D., Dillon T.J., and Stork P.J. Somatostatin activation of mitogen-activated protein kinase via somatostatin receptor 1 (SSTR1). Mol. Endocrinol. 13 1 (1999) 24-37
43. Freund T.F., and Buzsaki G. Interneurons of the hippocampus. Hippocampus 6 4 (1996) 347-470
44. Gabriel S.M., Davidson M., Haroutunian V., Powchik P., Bierer L.M., Purohit D.P., Perl D.P., and Davis K.L. Neuropeptide deficits in schizophrenia vs. Alzheimer's disease cerebral cortex. Biol. Psychiatry 39 2 (1996) 82-91
45. Gerachshenko T., Blackmer T., Yoon E.-J., Bartleson C., Hamm H.E., and Alford S. G[beta][gamma] acts at the C terminus of SNAP-25 to mediate presynaptic inhibition. Nat. Neurosci. 8 5 (2005) 597-605
46. Grouselle D., Winsky-Sommerer R., David J.P., Delacourte A., Dournaud P., and Epelbaum J. Loss of somatostatin-like immunoreactivity in the frontal cortex of Alzheimer patients carrying the apolipoprotein epsilon 4 allele. Neurosci. Lett. 255 1 (1998) 21-24
47. Halabisky B., Shen F., Huguenard J.R., and Prince D.A. Electrophysiological classification of somatostatin-positive interneurons in mouse sensorimotor cortex. J. Neurophysiol. 96 2 (2006) 834-845
48. Handel M., Schulz S., Stanarius A., Schreff M., Erdtmann-Vourliotis M., Schmidt H., Wolf G., and Hollt V. Selective targeting of somatostatin receptor 3 to neuronal cilia. Neuroscience 89 3 (1999) 909-926
49. Hashimoto T., and Obata K. Induction of somatostatin by kainic acid in pyramidal and granule cells of the rat hippocampus. Neurosci. Res. 12 4 (1991) 514-527
50. Hayashi M., Yamashita A., and Shimizu K. Somatostatin and brain-derived neurotrophic factor mRNA expression in the primate brain: decreased levels of mRNAs during aging. Brain Res. 749 2 (1997) 283-289
51. Hervieu G., and Emson P.C. The localization of somatostatin receptor 1 (sst1) immunoreactivity in the rat brain using an N-terminal specific antibody. Neuroscience 85 4 (1998) 1263-1284
52. Holm I.E., Geneser F.A., and Zimmer J. Somatostatin- and neuropeptide Y-like immunoreactivity in the dentate area, hippocampus, and subiculum of the domestic pig. J. Comp. Neurol. 322 3 (1992) 390-408
53. Huang S.M., Mouri A., Kokubo H., Nakajima R., Suemoto T., Higuchi M., Staufenbiel M., Noda Y., Yamaguchi H., Nabeshima T., Saido T.C., and Iwata N. Neprilysin-sensitive synapse-associated Abeta oligomers impair neuronal plasticity and cognitive function. J. Biol. Chem. 281 26 (2006) 17941-17951
54. Ikeda S.R., and Schofield G.G. Somatostatin blocks a calcium current in rat sympathetic ganglion neurons. J. Physiol. 409 (1989) 221-240
55. Inoue M., Nakajima S., and Nakajima Y. Somatostatin induces an inward rectification in rat locus coeruleus neurons through a pertussis toxin sensitive mechanism. J. Physiol. 407 (1988) 177-198
56. Ishihara S., Hassan S., Kinoshita Y., Moriyama N., Fukuda R., Maekawa T., Okada A., and Chiba T. Growth inhibitory effects of somatostatin on human leukemia cell lines mediated by somatostatin receptor subtype 1. Peptides 20 3 (1999) 313-318
57. Iwata N., Takaki Y., Fukami S., Tsubuki S., and Saido T.C. Region-specific reduction of A beta-degrading endopeptidase, neprilysin, in mouse hippocampus upon aging. J. Neurosci. Res. 70 3 (2002) 493-500
58. Jinno S., and Kosaka T. Colocalization of parvalbumin and somatostatin-like immunoreactivity in the mouse hippocampus: quantitative analysis with optical dissector. J. Comp. Neurol. 428 3 (2000) 377-388
59. Johansen F.F., Zimmer J., and Diemer N.H. Early loss of somatostatin neurons in dentate hilus after cerebral ischemia in the rat precedes CA-1 pyramidal cell loss. Acta Neuropathol. 73 2 (1987) 110-114
60. Kauer J.A., Malenka R.C., and Nicoll R.A. A persistent postsynaptic modification mediates long-term potentiation in the hippocampus. Neuron 1 10 (1988) 911-917
61. Kimura N., Tomizawa S., Arai K.N., and Osamura R.Y. Characterization of 5′-flanking region of rat somatostatin receptor sst2 gene: transcriptional regulatory elements and activation by Pitx1 and estrogen. Endocrinology 142 4 (2001) 1427-1441
62. Kobayashi M., and Buckmaster P.S. Reduced inhibition of dentate granule cells in a model of temporal lobe epilepsy. J. Neurosci. 23 6 (2003) 2440-2452
63. Kong H., Depaoli A.M., Breder C.D., Yasuda K., Bell G.I., and Reisine T. Differential expression of messenger RNAs for somatostatin receptor subtypes SSTR1, SSTR2, and SSTR3 in adult rat brain: analysis by RNA blotting and in situ hybridization histochemistry. Neuroscience 59 1 (1994) 175-184
64. Kosaka T., Wu J.-Y., and Benoit R. GABAergic neurons containing somatostatin-like immunoreactivity in the rat hippocampus and dentate gyrus. Exp. Brain Res. 71 (1988) 388-398
65. Kragh J., Tonder N., Finsen B.R., Zimmer J., and Bolwig T.G. Repeated electroconvulsive shocks cause transient changes in rat hippocampal somatostatin and neuropeptide Y immunoreactivity and mRNA in situ hybridization signals. Exp. Brain Res. 98 2 (1994) 305-313
66. Kumar U. Expression of somatostatin receptor subtypes (SSTR1-5) in Alzheimer's disease brain: an immunohistochemical analysis. Neuroscience 134 2 (2005) 525-538
67. Lahlou H., Guillermet J., Hortala M., Vernejoul F., Pyronnet S., Bousquet C., and Susini C. Molecular signaling of somatostatin receptors. Ann. N.Y. Acad. Sci. 1014 1 (2004) 121-131
68. Lahlou H., Saint-Laurent N., Esteve J.P., Eychene A., Pradayrol L., Pyronnet S., and Susini C. sst2 Somatostatin receptor inhibits cell proliferation through Ras-, Rap1-, and B-Raf-dependent ERK2 activation. J. Biol. Chem. 278 41 (2003) 39356-39371
69. Lahteinen S., Pitkanen A., Koponen E., Saarelainen T., and Castren E. Exacerbated status epilepticus and acute cell loss, but no changes in epileptogenesis, in mice with increased brain-derived neurotrophic factor signaling. Neuroscience 122 4 (2003) 1081-1092
70. Le Gal La Salle G. Long-lasting and sequential increase of c-fos oncoprotein expression in kainic acid-induced status epilepticus. Neurosci. Lett. 88 2 (1988) 127-130
71. Leranth C., Malcolm A.J., and Frotscher M. Afferent and efferent synaptic connections of somatostatin-immunoreactive neurons in the rat fascia dentata. J. Comp. Neurol. 295 1 (1990) 111-122
72. Leroux P., Weissmann D., Pujol J.-F., and Vaudry H. Quantitative autoradiography of somatostatin receptors in the rat limbic system. J. Comp. Neurol. 331 (1993) 389-401
73. Lowenstein D.H., Thomas M.J., Smith D.H., and Mcintosh T.K. Selective vulnerability of dentate hilar neurons following traumatic brain injury: a potential mechanistic link between head trauma and disorders of the hippocampus. J. Neurosci. 12 12 (1992) 4846-4853
74. Lubke J., Frotscher M., and Spruston N. Specialized electrophysiological properties of anatomically identified neurons in the hilar region of the rat fascia dentata. J. Neurophysiol. 79 3 (1998) 1518-1534
75. Manfridi A., Forloni G.L., Vezzani A., Fodritto F., and De Simoni M.G. Functional and histological consequences of quinolinic and kainic acid-induced seizures on hippocampal somatostatin neurons. Neuroscience 41 1 (1991) 127-135
76. Marti M., Bregola G., Morari M., Gemignani A., and Simonato M. Somatostatin release in the hippocampus in the kindling model of epilepsy: a microdialysis study. J. Neurochem. 74 6 (2000) 2497-2503
77. Mathern G.W., Babb T.L., Pretorius J.K., and Leite J.P. Reactive synaptogenesis and neuron densities for neuropeptide Y, somatostatin, and glutamate decarboxylase immunoreactivity in the epileptogenic human fascia dentata. J. Neurosci. 15 5 pt 2 (1995) 3990-4004
78. Mazarati A.M., and Telegdy G. Effects of somatostatin and anti-somatostatin serum on picrotoxin-kindled seizures. Neuropharmacology 31 8 (1992) 793-797
79. Mcdonald A.J. Coexistence of somatostatin with neuropeptide Y, but not with cholecystokinin or vasoactive intestinal peptide, in neurons of the rat amygdala. Brain Res. 500 1-2 (1989) 37-45
80. Meriney S.D., Gray D.B., and Pilar G.R. Somatostatin-induced inhibition of neuronal calcium current modulated by cGMP-dependent protein kinase. Nature 369 6478 (1994) 336-339
81. Mihara S., North R.A., and Surprenant A. Somatostatin increases an inwardly rectifying potassium conductance in guinea pig submucosa plexus neurones. J. Physiol. 390 (1987) 335-355
82. Mikkelsen J.D., and Woldbye D.P. Accumulated increase in neuropeptide Y and somatostatin gene expression of the rat in response to repeated electroconvulsive stimulation. J. Psychiatr. Res. 40 2 (2006) 153-159
83. Milner T.A., and Bacon C.E. Ultrastructural localization of somatostatin-like immunoreactivity in the rat dentate gyrus. J. Comp. Neurol. 290 4 (1989) 544-560
84. Minthon L., Edvinsson L., and Gustafson L. Somatostatin and neuropeptide Y in cerebrospinal fluid: correlations with severity of disease and clinical signs in Alzheimer's disease and frontotemporal dementia. Dement. Geriatr. Cogn. Disord. 8 4 (1997) 232-239
85. Mitchell T.W., Buckmaster P.S., Hoover E.A., Whalen L.R., and Dudek F.E. Neuron loss and axon reorganization in the dentate gyrus of cats infected with the feline immunodeficiency virus. J. Comp. Neurol. 411 4 (1999) 563-577
86. Moller L.N., Stidsen C.E., Hartmann B., and Holst J.J. Somatostatin receptors. Biochim. Biophys. Acta 1616 1 (2003) 1-84
87. Montminy M., Brindle P., Arias J., Ferreri K., and Armstrong R. Regulation of somatostatin gene transcription by cyclic adenosine monophosphate. Metabolism 45 8 Suppl 1 (1996) 4-7
88. Montminy M.R., and Bilezikjian L.M. Binding of a nuclear protein to the cyclic-AMP response element of the somatostatin gene. Nature 328 6126 (1987) 175-178
89. Moore S.D., Madamba S.G., Joels M., and Siggins G.R. Somatostatin augments the M-current in hippocampal neurons. Science 239 4837 (1988) 278-280
90. Moser E.I., Krobert K.A., Moser M.B., and Morris R.G. Impaired spatial learning after saturation of long-term potentiation. Science 281 5385 (1998) 2038-2042
91. Mott D.D., Turner D.A., Okazaki M.M., and Lewis D.V. Interneurons of the dentate-hilus border of the rat dentate gyrus: morphological and electrophysiological heterogeneity. J. Neurosci. 17 11 (1997) 3990-4005
92. Nakao K., Ikegaya Y., Yamada M.K., Nishiyama N., and Matsuki N. Hippocampal long-term depression as an index of spatial working memory. Eur. J. Neurosci. 16 5 (2002) 970-974
93. Nakatani N., Hattori E., Ohnishi T., Dean B., Iwayama Y., Matsumoto I., Kato T., Osumi N., Higuchi T., Niwa S.I., and Yoshikawa T. Genome-wide expression analysis detects eight genes with robust alterations specific to bipolar I disorder: relevance to neuronal network perturbation. Hum. Mol. Genet. 15 12 (2006) 1949-1962
94. Nemeroff C.B., Youngblood W.W., Manberg P.J., Prange Jr. A.J., and Kizer J.S. Regional brain concentrations of neuropeptides in Huntington's chorea and schizophrenia. Science 221 4614 (1983) 972-975
95. Neves S.R., Ram P.T., and Iyengar R. G protein pathways. Science 296 5573 (2002) 1636-1639
96. Oliva Jr. A.A., Jiang M., Lam T., Smith K.L., and Swann J.W. Novel hippocampal interneuronal subtypes identified using transgenic mice that express green fluorescent protein in GABAergic interneurons. J. Neurosci. 20 9 (2000) 3354-3368
97. Passarelli F., and Orzi F. Somatostatin mRNA in the hippocampal formation following electroconvulsive shock in the rat. Neurosci. Lett. 153 2 (1993) 197-201
98. Peng Z., and Houser C.R. Temporal patterns of fos expression in the dentate gyrus after spontaneous seizures in a mouse model of temporal lobe epilepsy. J. Neurosci. 25 31 (2005) 7210-7220
99. 2 and differential changes in somatostatin receptor messenger RNAs, binding sites and somatostatin release in kainic acid-treated rats. Neuroscience 65 4 (1995) 1087-1097
100. Piwko C., Thoss V.S., Samanin R., Hoyer D., and Vezzani A. Status of somatostatin receptor messenger RNAs and binding sites in rat brain during kindling epileptogenesis. Neuroscience 75 3 (1996) 857-868
101. Pola S., Cattaneo M.G., and Vicentini L.M. Anti-migratory and anti-invasive effect of somatostatin in human neuroblastoma cells: involvement of Rac and MAP kinase activity. J. Biol. Chem. 278 42 (2003) 40601-40606
102. Powers A.C., Tedeschi F., Wright K.E., Chan J.S., and Habener J.F. Somatostatin gene expression in pancreatic islet cells is directed by cell-specific DNA control elements and DNA-binding proteins. J. Biol. Chem. 264 17 (1989) 10048-10056
103. Qiu, C., Suntheimer, R.J. and Tallent, M.K. (2003). Somatostatin depresses CA1 long term potentiation. Abstract Viewer/Itinerary Planner. Washington, DC: Society for Neuroscience, Program No. 889.1.
104. Qiu, C., Suzuki, C., Zeyda, T., Hochgeschwender, U., de Lecea, L. and Tallent, M.K. (2005). Increased seizure severity and reduced somatostatin effects in hippocampus of somatostatin receptor subtype 4 (SST4) knockout mice. 2005 Abstract Viewer/Itinerary Planner. Washington, DC: Society for Neuroscience, Program No. 607.11.
105. Ramirez J.L., Gracia-Navarro F., Garcia-Navarro S., Torronteras R., Malagon M.M., and Castano J.P. Somatostatin stimulates GH secretion in two porcine somatotrope subpopulations through a cAMP-dependent pathway. Endocrinology 143 3 (2002) 889-897
106. Ramos B., Baglietto-Vargas D., Del Rio J.C., Moreno-Gonzalez I., Santa-Maria C., Jimenez S., Caballero C., Lopez-Tellez J.F., Khan Z.U., Ruano D., Gutierrez A., and Vitorica J. Early neuropathology of somatostatin/NPY GABAergic cells in the hippocampus of a PS1×APP transgenic model of Alzheimer's disease. Neurobiol. Aging 27 11 (2006) 1658-1672
107. Rapp P.R., and Amaral D.G. The time of origin of somatostatin-immunoreactive neurons in the rat hippocampal formation. Brain Res. 469 1-2 (1988) 231-239
108. Rauca C., Schafer K., and Hollt V. Effects of somatostatin, octreotide and cortistatin on ischaemic neuronal damage following permanent middle cerebral artery occlusion in the rat. Naunyn. Schmiedebergs Arch. Pharmacol. 360 6 (1999) 633-638
109. Raynor K., and Reisine T. Differential coupling of somatostatin1 receptors to adenylyl cyclase in the rat striatum vs. the pituitary and other regions of the rat brain. J. Pharmacol. Exp. Ther. 260 (1992) 841-848
110. Reisine T. Somatostatin. Cell Mol. Neurobiol. 15 6 (1995) 597-614
111. Robbins R.J., Brines M.L., Kim J.H., Adrian T., De Lanerolle N., Welsh S., and Spencer D.D. A selective loss of somatostatin in the hippocampus of patients with temporal lobe epilepsy. Ann. Neurol. 29 3 (1991) 325-332
112. Roberts G.W., Crow T.J., and Polak J.M. Location of neuronal tangles in somatostatin neurons in Alzheimer's disease. Nature 314 (1985) 92-94
113. Robishaw J.D., and Berlot C.H. Translating G protein subunit diversity into functional specificity. Curr. Opin. Cell Biol. 16 2 (2004) 206-209
114. Saito T., Iwata N., Tsubuki S., Takaki Y., Takano J., Huang S.M., Suemoto T., Higuchi M., and Saido T.C. Somatostatin regulates brain amyloid beta peptide Abeta42 through modulation of proteolytic degradation. Nat. Med. 11 4 (2005) 434-439
115. Sakai K., Maeda K., Chihara K., and Kaneda H. Increases in cortical neuropeptide Y and somatostatin concentrations following haloperidol-depot treatment in rats. Neuropeptides 29 3 (1995) 157-161
116. Scharfman H.E. Differentiation of rat dentate neurons by morphology and electrophysiology in hippocampal slices: granule cells, spiny hilar cells and aspiny 'fast-spiking' cells. Epilepsy Res. Suppl. 7 (1992) 93-109
117. Schindler M., Humphrey P.P., Lohrke S., and Friauf E. Immunohistochemical localization of the somatostatin sst2(b) receptor splice variant in the rat central nervous system. Neuroscience 90 3 (1999) 859-874
118. Schreff M., Schulz S., Handel M., Keilhoff G., Braun H., Pereira G., Klutzny M., Schmidt H., Wolf G., and Hollt V. Distribution, targeting, and internalization of the sst4 somatostatin receptor in rat brain. J. Neurosci. 20 10 (2000) 3785-3797
119. Schulz S., Handel M., Schreff M., Schmidt H., and Hollt V. Localization of five somatostatin receptors in the rat central nervous system using subtype-specific antibodies. J. Physiol. Paris 94 3-4 (2000) 259-264
120. Schwarzer C., Sperk G., Samanin R., Rizzi M., Gariboldi M., and Vezzani A. Neuropeptides-immunoreactivity and their mRNA expression in kindling: functional implications for limbic epileptogenesis. Brain Res. Brain Res. Rev. 22 1 (1996) 27-50
121. Schweitzer P., Madamba S., and Siggins G.R. Arachidonic acid metabolites as mediators of somatostatin-induced increase of neuronal M-current. Nature 346 6283 (1990) 464-467
122. + conductance in rat CA1 hippocampal neurons. J. Neurophysiol. 79 3 (1998) 1230-1238
123. Schweitzer P., Madamba S.G., and Siggins G.R. The sleep-modulating peptide cortistatin augments the h-current in hippocampal neurons. J. Neurosci. 23 34 (2003) 10884-10891
124. Sharma R.P., Bissette G., Janicak P.G., Davis J.M., and Nemeroff C.B. Elevation of CSF somatostatin concentrations in mania. Am. J. Psychiatry 152 12 (1995) 1807-1809
125. Siehler S., and Hoyer D. Characterisation of human recombinant somatostatin receptors. 4. Modulation of phospholipase C activity. Naunyn Schmiedebergs Arch. Pharmacol. 360 5 (1999) 522-532
126. Simonato M., Bregola G., Beani L., Vezzani A., Sala R., Raiteri M., and Bonanno G. Time- and region-specific variations in somatostatin release following amygdala kindling in the rat. J. Neurochem. 70 1 (1998) 252-259
127. Sloviter R.S. Decreased hippocampal inhibition and a selective loss of interneurons in experimental epilepsy. Science 235 4784 (1987) 73-76
128. Sodickson D.L., and Bean B.P. Neurotransmitter activation of inwardly rectifying potassium current in dissociated hippocampal CA3 neurons: interactions among multiple receptors. J. Neurosci. 18 20 (1998) 8153-8162
129. Sokal D.M., and Large C.H. The effects of GABA(B) receptor activation on spontaneous and evoked activity in the dentate gyrus of kainic acid-treated rats. Neuropharmacology 40 2 (2001) 193-202
130. Straiker A.J., Borden C.R., and Sullivan J.M. G-protein alpha subunit isoforms couple differentially to receptors that mediate presynaptic inhibition at rat hippocampal synapses. J. Neurosci. 22 7 (2002) 2460-2468
131. Stroh T., Kreienkamp H.J., and Beaudet A. Immunohistochemical distribution of the somatostatin receptor subtype 5 in the adult rat brain: predominant expression in the basal forebrain. J. Comp. Neurol. 412 1 (1999) 69-82
132. Sutula T., and Steward O. Quantitative analysis of synaptic potentiation during kindling of the perforant path. J. Neurophysiol. 56 3 (1986) 732-746
133. Sutula T., and Steward O. Facilitation of kindling by prior induction of long-term potentiation in the perforant path. Brain Res. 420 1 (1987) 109-117
134. Swanson T.H., Sperling M.R., and O'connor M.J. Strong paired pulse depression of dentate granule cells in slices from patients with temporal lobe epilepsy. J. Neural Transm. 105 6-7 (1998) 613-625
135. Tallent M.K., Fabre V., Qiu C., Calbet M., Lamp T., Baratta M.V., Suzuki C., Levy C.L., Siggins G.R., and Henriksen S.J. Cortistatin overexpression in transgenic mice produces deficits in synaptic plasticity and learning. Mol. Cell. Neurosci. 30 3 (2005) 465-475
136. Tallent, M.K., Patterson, C., Hon, B., Qiu, C., Zeyda, T., Hochgeschwender, U. and de Lecea, L. (2005b). Somatostatin receptor subtype 3 is critical for hippocampal-dependent memory: studies in SST3 receptor knockout mice. Abstract Viewer/Itinerary Planner. Washington, DC: Society for Neuroscience, Program No. 607.10.
137. Tallent M.K., and Siggins G.R. Somatostatin depresses excitatory but not inhibitory neurotransmission in rat CA1 hippocampus. J. Neurophysiol. 78 6 (1997) 3008-3018
138. Tallent M.K., and Siggins G.R. Somatostatin acts in CA1 and CA3 to reduce hippocampal epileptiform activity. J. Neurophysiol. 81 4 (1999) 1626-1635
139. Tentler J.J., Hadcock J.R., and Gutierrez-Hartmann A. Somatostatin acts by inhibiting the cyclic 3′,5′-adenosine monophosphate (cAMP)/protein kinase A pathway, cAMP response element-binding protein (CREB) phosphorylation, and CREB transcription potency. Mol. Endocrinol. 11 7 (1997) 859-866
140. Thoss V.S., Duc D., and Hoyer D. Somatostatin receptors in the developing rat brain. Eur. J. Pharmacol. 297 1-2 (1996) 145-155
141. Thoss V.S., Perez J., Duc D., and Hoyer D. Embryonic and postnatal mRNA distribution of five somatostatin receptor subtypes in the rat brain. Neuropharmacology 34 12 (1995) 1673-1688
142. Todisco A., Campbell V., Dickinson C.J., Delvalle J., and Yamada T. Molecular basis for somatostatin action: inhibition of c-fos expression and AP-1 binding. Am. J. Physiol. Gastrointest. Liver Physiol. 267 2 (1994) G245-G253
143. Todisco A., Seva C., Takeuchi Y., Dickinson C.J., and Yamada T. Somatostatin inhibits AP-1 function via multiple protein phosphatases. Am. J. Physiol. 269 1 Pt 1 (1995) G160-G166
144. Tomidokoro Y., Harigaya Y., Matsubara E., Ikeda M., Kawarabayashi T., Okamoto K., and Shoji M. Impaired neurotransmitter systems by Abeta amyloidosis in APPsw transgenic mice overexpressing amyloid beta protein precursor. Neurosci. Lett. 292 3 (2000) 155-158
145. Vecsei L., Csala B., Widerlov E., Ekman R., Czopf J., and Palffy G. Lumbar cerebrospinal fluid concentrations of somatostatin and neuropeptide Y in multiple sclerosis. Brain Res. Bull. 25 3 (1990) 411-413
146. Vela J., Gutierrez A., Vitorica J., and Ruano D. Rat hippocampal GABAergic molecular markers are differentially affected by ageing. J. Neurochem. 85 2 (2003) 368-377
147. Velimirovic B.M., Koyano K., Nakajima S., and Nakajima Y. Opposing mechanisms of regulation of a G-protein-coupled inward rectifier K+ channel in rat brain neurons. Proc. Natl. Acad. Sci. U.S.A. 92 5 (1995) 1590-1594
148. Vezzani A., Monno A., Rizzi M., Galli A., Barrios M., and Samanin R. Somatostatin release is enhanced in the hippocampus of partially and fully kindled rats. Neuroscience 51 1 (1992) 41-46
149. Vezzani A., Rizzi M., Conti M., and Samanin R. Modulatory role of neuropeptides in seizures induced in rats by stimulation of glutamate receptors. J. Nutr. 130 4S Suppl (2000) 1046S-1048S
150. Vezzani A., Schwarzer C., Lothman E.W., Williamson J., and Sperk G. Functional changes in somatostatin and neuropeptide Y containing neurons in the rat hippocampus in chronic models of limbic seizures. Epilepsy Res. 26 1 (1996) 267-279
151. Vezzani A., Serafini R., Stasi M.A., Vigano G., Rizzi M., and Samanin R. A peptidase-resistant cyclic octapeptide analogue of somatostatin (SMS 201-995) modulates seizures induced by quinolic acid and kainic acid differently in the rat hippocampus. Neuropharmacology 30 4 (1991) 345-352
152. Wang H.-L., Dichter M.A., and Reisine T. Lack of cross-desensitization of somatostatin-14 and somatostatin-28 receptors coupled to potassium channels in rat neocortical neurons. Mol. Pharm. 38 3 (1990) 357-361
153. Wang H.-L., Reisine T., and Dichter M.A. Somatostatin-14 and somatostatin-28 inhibit calcium currents in rat neocortical neurons. Neuroscience 38 2 (1990) 335-342
154. Wasterlain C.G., Mazarati A.M., Shirasaka Y., Thompson K.W., Penix L., Liu H., and Katsumori H. Seizure-induced hippocampal damage and chronic epilepsy: a hebbian theory of epileptogenesis. Adv. Neurol. 79 (1999) 829-843
155. Winsky-Sommerer R., Spier A.D., Fabre V., de Lecea L., and Criado J.R. Overexpression of the human beta-amyloid precursor protein downregulates cortistatin mRNA in PDAPP mice. Brain Res. 1023 1 (2004) 157-162
156. Yoshitomi H., Fujii Y., Miyazaki M., Nakajima N., Inagaki N., and Seino S. Involvement of MAP kinase and c-fos signaling in the inhibition of cell growth by somatostatin. Am. J. Physiol. 272 5 Pt 1 (1997) E769-E774
157. Yasojima K., Akiyama H., Mcgeer E.G., and Mcgeer P.L. Reduced neprilysin in high plaque areas of Alzheimer brain: a possible relationship to deficient degradation of beta-amyloid peptide. Neurosci. Lett. 297 2 (2001) 97-100
158. Yus-Najera E., Munoz A., Salvador N., Jensen B.S., Rasmussen H.B., Defelipe J., and Villarroel A. Localization of KCNQ5 in the normal and epileptic human temporal neocortex and hippocampal formation. Neuroscience 120 2 (2003) 353-364
159. Zhang Z.J., Lappi D.A., Wrenn C.C., Milner T.A., and Wiley R.G. Selective lesion of the cholinergic basal forebrain causes a loss of cortical neuropeptide Y and somatostatin neurons. Brain Res. 800 2 (1998) 198-206
160. Zheng H., Bailey A., Jiang M.H., Honda K., Chen H.Y., Trumbauer M.E., Van Der Ploeg L.H., Schaeffer J.M., Leng G., and Smith R.G. Somatostatin receptor subtype 2 knockout mice are refractory to growth hormone-negative feedback on arcuate neurons. Mol. Endocrinol. 11 11 (1997) 1709-1717